Major systemic infection following breast cancer surgery and oncological outcomes - Takeaways - MDSpire

Major systemic infection following breast cancer surgery and oncological outcomes

  • By

  • Linda Adwall

  • Irma Fredriksson

  • Hella Hultin

  • Peter Stålberg

  • Maria Mani

  • Olov Norlén

  • Helena Sackey

  • December 2, 2025

  • 0 min

Share

  • 1

    Major systemic infections within 90 days post-breast cancer surgery are linked to increased distant recurrence risk.

  • 2

    The study analyzed data from 82,102 patients who underwent breast cancer surgery in Sweden from 2008 to 2019.

  • 3

    1.8% of patients experienced major systemic infections, while 0.6% faced other major events within 90 days post-surgery.

  • 4

    Major systemic infections were associated with higher overall death and breast cancer-specific death rates.

  • 5

    The findings emphasize the need for timely treatment of postoperative infections to improve oncological outcomes.

Original Source(s)

Major systemic infection following breast cancer surgery and oncological outcomes

  • by Linda Adwall, Irma Fredriksson, Hella Hultin, Peter Stålberg, Maria Mani, Olov Norlén, Helena Sackey

  • December 2, 2025

Related Content

Clinician Perspectives on Implementing Breast Cancer–Related Lymphedema Prospective Screening

Editorial: Emerging trends in moyamoya disease: diagnostic and therapeutic innovations

Mesh-free prepectoral breast reconstruction: a safe and effective alternative